HLB Therapeutics Co (XKRX:115450) Scaled Net Operating Assets : 0.89 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

HLB Therapeutics Co's operating assets for the quarter that ended in Mar. 2024 was ₩211,953 Mil. HLB Therapeutics Co's operating liabilities for the quarter that ended in Mar. 2024 was ₩33,230 Mil. HLB Therapeutics Co's Total Assets for the quarter that ended in Dec. 2023 was ₩200,795 Mil. Therefore, HLB Therapeutics Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.89.

HLB Therapeutics Co Scaled Net Operating Assets Historical Data

The historical data trend for HLB Therapeutics Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Scaled Net Operating Assets Chart

HLB Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.71

0.61

0.66

0.61

0.80

HLB Therapeutics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.77	0.77	0.71	0.70	0.89

Competitive Comparison of HLB Therapeutics Co's Scaled Net Operating Assets

For the Biotechnology subindustry, HLB Therapeutics Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Therapeutics Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Scaled Net Operating Assets falls into.

HLB Therapeutics Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

HLB Therapeutics Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(168442.284	-	19253.642)	/	187643.258
=	0.80

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	200794.853	-	32352.569
=	168442.284

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	29275.991	-	1962.389	-	8059.96
=	19253.642

HLB Therapeutics Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(211953.051	-	33229.754)	/	200794.853
=	0.89

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	211953.051	-	0
=	211953.051

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	33229.754	-	0	-	0
=	33229.754

HLB Therapeutics Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Therapeutics Co (XKRX:115450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines